Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
ExpreS2ion Biotech Holding AB banner

ExpreS2ion Biotech Holding AB
STO:EXPRS2

Watchlist Manager
ExpreS2ion Biotech Holding AB Logo
ExpreS2ion Biotech Holding AB
STO:EXPRS2
Watchlist
Price: 0.99 SEK -5.71%
Market Cap: kr23.5m
Write Note Create Alert

Wall St Price Targets

EXPRS2 Price Forecast
Based on 3 analysts

+415% Upside
from kr0.99 today

ExpreS2ion Biotech Holding AB (EXPRS2)’s 12-month stock price forecast through October 2027 has a consensus target of kr5.1, implying 415% upside. The forecast is based on price targets from 3 Wall Street analysts.

EXPRS2 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for EXPRS2 yet.

ExpreS2ion Biotech Holding AB Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Continue EXPRS2 Research

Summary
EXPRS2 intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXPRS2 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXPRS2 stock valuation using valuation multiples.
Wall St Estimates
EXPRS2 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXPRS2 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other ExpreS2ion Biotech Holding AB listings:
F • EUR
5JD0
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EXPRS2's stock price target?
Price Target
5.1 SEK

According to Wall Street analysts, the average 1-year price target for EXPRS2 is 5.1 SEK with a low forecast of 5.05 SEK and a high forecast of 5.25 SEK.

What is the Revenue forecast for ExpreS2ion Biotech Holding AB?
Projected CAGR
39%

The compound annual growth rate for Revenue over the next 3 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join 362,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.